Abstract
Objective:
To assess the etiology, prognosis, and appropriate treatment of hemophagocytic lymphohistiocytosis (HLH) in neonates.
Study design:
We collected information on neonates in whom HLH was diagnosed between 1997 and 2007 from participating members of the Japanese Society of Pediatric Hematology.
Results:
HLH was diagnosed in 20 patients within 4 weeks after birth. Of the diagnostic criteria for HLH-2004, the incidence of fever was quite low in preterm infants, and hypertriglyceridemia and neutropenia were uncommon. Familial HLH (n = 6) or severe combined immunodeficiency-associated HLH (n = 1) was diagnosed in 7 patients, and 2 of them have survived. Herpes simplex virus-associated HLH was diagnosed in 6 patients, and 2 of them have survived. The overall survival rate for the 20 patients was 40%.
Conclusions:
HLH is rare in neonates and has a poor prognosis. Early diagnosis and immediate treatment are required when considering the possibility of herpes simplex virus-associated or familial HLH.
MeSH terms
-
Acyclovir / therapeutic use
-
Adrenal Cortex Hormones / therapeutic use
-
Antineoplastic Agents, Phytogenic / therapeutic use
-
Antiviral Agents / therapeutic use
-
Consciousness Disorders / epidemiology
-
Cyclosporine / therapeutic use
-
Erythema / epidemiology
-
Etoposide / therapeutic use
-
Exanthema / epidemiology
-
Female
-
Fetal Distress / epidemiology
-
Fever / epidemiology
-
Hematopoietic Stem Cell Transplantation
-
Herpes Simplex / diagnosis
-
Herpes Simplex / drug therapy
-
Herpes Simplex / epidemiology
-
Humans
-
Immunologic Factors / therapeutic use
-
Immunosuppressive Agents / therapeutic use
-
Infant, Newborn
-
Infant, Premature
-
Japan
-
L-Lactate Dehydrogenase / blood
-
Leukocytosis / epidemiology
-
Lymphohistiocytosis, Hemophagocytic / diagnosis*
-
Lymphohistiocytosis, Hemophagocytic / mortality*
-
Lymphohistiocytosis, Hemophagocytic / therapy
-
Male
-
Ocular Motility Disorders / epidemiology
-
Plasma Exchange
-
Prognosis
-
Respiratory Distress Syndrome, Newborn / epidemiology
-
Seizures / epidemiology
-
Severe Combined Immunodeficiency / diagnosis
-
Severe Combined Immunodeficiency / epidemiology
-
beta 2-Microglobulin / urine
-
gamma-Globulins / therapeutic use
Substances
-
Adrenal Cortex Hormones
-
Antineoplastic Agents, Phytogenic
-
Antiviral Agents
-
Immunologic Factors
-
Immunosuppressive Agents
-
beta 2-Microglobulin
-
gamma-Globulins
-
Etoposide
-
Cyclosporine
-
L-Lactate Dehydrogenase
-
Acyclovir